Menu

GM Study Declared Unsound

A controversial study that suggested genetically modified (GM) maize causes cancer in rats is dismissed by the European Food Safety Authority.

Nov 29, 2012
Jef Akst

Wikimedia, Sreejith KA task force set up by the European Food Safety Authority (EFSA) yesterday (November 28) has confirmed suspicions that a September study claiming to have identified serious health consequences of genetically modified (GM) maize “does not meet acceptable scientific standards.”

The 2-year-long study examined rats fed a Europe- and United States-approved GM corn, called NK603, and claimed they developed massive mammary tumors and died earlier than rats fed conventional corn. The results, which were published in September in Food and Chemical Toxicology, were met with immediate skepticism, leading to an independent evaluation by two French regulatory agencies and the EFSA. Last month (October 4), the EFSA announced its preliminary conclusion that “the design, reporting and analysis of the study, as outlined in the paper, are inadequate.” Now, the agency has declared with more certainty that the study “does not meet acceptable scientific standards, and there is no need to re-examine previous safety evaluations of genetically modified maize NK603.”

The European Union uses millions of tons of GM crops, including NK603 corn, as livestock feed.

(Hat tip to ScienceInsider)

April 2019

Will Car T Cells Smash Tumors?

New trials take the therapy beyond the blood

Marketplace

Sponsored Product Updates

Getting More Consistent Results by Knowing the Quality of Your Protein
Getting More Consistent Results by Knowing the Quality of Your Protein
Download this guide from NanoTemper to learn how to identify and evaluate the quality of your protein samples!
Myth Busting: The Best Way to Use Pure Water in the Lab
Myth Busting: The Best Way to Use Pure Water in the Lab
Download this white paper from ELGA LabWater to learn about the role of pure water in the laboratory and the advantages of in-house water purification!
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu Corporation announces the release of the Nexera Ultra High-Performance Liquid Chromatograph series, incorporating artificial intelligence as Analytical Intelligence, allowing systems to detect and resolve issues automatically. The Nexera series makes lab management simple by integrating IoT and device networking, enabling users to easily review instrument status, optimize resource allocation, and achieve higher throughput.
IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system
IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system
Increasing accuracy and reducing cost barriers, IDT’s innovative system delivers simple and cost-effective amplicon sequencing